GLDC Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of GLDC Antibodies for investigating glycine decarboxylase (GLDC) in research applications. Monoclonal GLDC Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GLDC plays a crucial role in the glycine cleavage system, which is essential for the catabolism of glycine and the regulation of one-carbon metabolism. GLDC functions in various physiological processes, including neurotransmission and metabolic pathways, and GLDC dysregulation has been linked to several neurological disorders. Understanding GLDC function and regulation is vital for advancing research in metabolic and neurodegenerative diseases. Researchers can utilize GLDC monoclonal antibodies to explore cellular pathways and molecular mechanisms involved in glycine metabolism. GLDC research continues to reveal new insights into metabolic disorders and potential therapeutic targets. Santa Cruz Biotechnology monoclonal GLDC antibodies support researchers worldwide in advancing scientific understanding of metabolic and neurological conditions.